[1] Thuluvath PJ, Hanish S, Savva Y. Liver transplantation in cryptogenic cirrhosis. Transplantation,2018,102:656-663.
[2] 朱冰,刘鸿凌,刘利敏,等. 4132例酒精性肝病临床特征分析. 中华肝脏病杂志,2015,23:680-683.
[3] 尚华,张国顺,孟冬梅,等. 乙型肝炎病毒感染合并酒精性肝病的失代偿期肝硬化患者并发肝衰竭的危险因素分析. 中国综合临床,2016,33:504-507.
[4] 吴安燕,邓世康,杨晋辉. 1545例肝硬化患者病因分析. 云南医药,2017,38:109-111.
[5] Benjamin J, Shasthry V, Kaal CR, et al. Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based study. Liver Int,2017,37:1668-1674.
[6] 高潇雪,刘立新. 1991至2015年国内外肝硬化患者中酒精病因构成比变化特点Meta分析. 中华消化病与影像杂志(电子版),2016,6:261-266.
[7] Mellinger J L, Shedden K, Winder GS, et al. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology,2018,26:67-69.
[8] Jiménez-Romero C. Incidence, risk factors and outcome ofde novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol,2015,7:942-944.
[9] Jeong JH, Park IS, Kim DH, et al. CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis. Medicine,2016,95:3935-3937.
[10] 何小谷,方向明,陈时,等. 肝炎后肝硬化和酒精性肝硬化患者临床特点分析. 中国综合临床,2015,31:60-62. |
